Split-hand index for the diagnosis of amyotrophic lateral sclerosis

Clin Neurophysiol. 2013 Feb;124(2):410-6. doi: 10.1016/j.clinph.2012.07.025. Epub 2012 Sep 25.

Abstract

Objective: Preferential wasting of the thenar group of muscles, the split hand sign, appears to be a specific feature of ALS. The present study developed a novel split-hand index (SI) and assessed its diagnostic utility in ALS.

Methods: One hundred and seventy consecutive patients with neuromuscular symptoms (44 ALS, 126 patients with other neuromuscular disorders) were prospectively recruited according to standards for reporting of diagnostic accuracy (STARD) criteria. The SI was derived by dividing the product of the compound muscle action potential (CMAP) amplitude recorded over the first dorsal interosseous and abductor pollicis brevis by the CMAP amplitude recorded over the abductor digiti minimi.

Results: The SI was significantly reduced in ALS patients (ALS 3.5 ± 0.6; patients with other neuromuscular disorders 9.1 ± 0.3, P < 0.0001), particularly in limb-onset ALS (2.3 ± 0.5, P < 0.0001). Receiver operating characteristic curve analysis indicated that SI reliably differentiated ALS from patients with other neuromuscular disorders (area under curve ALS 0.83, P < 0.0001) with an optimal SI cut-off value of 5.2 exhibiting a sensitivity of 74% and specificity 80%.

Conclusions: The split-hand index robustly differentiates ALS from mimic disorders.

Significance: The split-hand index is a simple measure that could be utilized in a standard neurophysiology setting. A reduction in SI distinguishes ALS from mimic disorders, potentially facilitating an earlier diagnosis of ALS.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / physiology
  • Adult
  • Aged
  • Aged, 80 and over
  • Amyotrophic Lateral Sclerosis / diagnosis*
  • Amyotrophic Lateral Sclerosis / physiopathology*
  • Diagnosis, Differential
  • Diagnostic Techniques, Neurological*
  • Disease Progression
  • Female
  • Humans
  • Male
  • Middle Aged
  • Muscular Atrophy / diagnosis*
  • Muscular Atrophy / physiopathology*
  • Neuromuscular Diseases / diagnosis
  • Neuromuscular Diseases / physiopathology
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Severity of Illness Index*